Dyfyniad APA

Fiorillo, M., Sotgia, F., Sisci, D., Cappello, A. R., & Lisanti, M. P. (2017). Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer. Oncotarget.

Dyfyniad Arddull Chicago

Fiorillo, Marco, Federica Sotgia, Diego Sisci, Anna Rita Cappello, and Michael P. Lisanti. "Mitochondrial “power” Drives Tamoxifen Resistance: NQO1 and GCLC Are New Therapeutic Targets in Breast Cancer." Oncotarget 2017.

Dyfyniad MLA

Fiorillo, Marco, et al. "Mitochondrial “power” Drives Tamoxifen Resistance: NQO1 and GCLC Are New Therapeutic Targets in Breast Cancer." Oncotarget 2017.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.